Lessons From Novartis' $678M Speaker Program Settlement

Partner John Bentivoglio, counsel Avia Dunn and associate Elizabeth Berry share their takeaways from Novartis' recent agreement to pay $678 million to settle False Claims Act litigation with the DOJ involving the company’s physician-led speaker programs. The settlement was the largest ever for speaker programs, one of the most common pharmaceutical industry marketing tactics.